Skip to main content
. 2017 Sep 29;8(17):3522–3530. doi: 10.7150/jca.20227

Figure 3.

Figure 3

The levels of HA, circulating CD14+CD204+ M2-like monocytes, CEA, and CA15-3 in patients with breast cancer and control subjects. (A) The levels of HA. (B) The percentages of circulating CD14+CD204+ M2-like monocytes. (C) and (D) The concentration of CEA and CA15-3, respectively. (E) The correlation between the percentages of circulating CD14+CD204+ M2-like monocytes and the levels of plasma HA in BC patients.